Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eso Technologies
AddedFeb 17, 2024
UpdatedJun 18, 2026
Eso Technologies

Eso Technologies

Pre-Seed

ESO-Tech, a medical device company, innovates safe, minimally invasive cardiac monitoring systems for enhanced patient care.

HQ
Middleton, WI, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

ESO-Tech is a medical device company focused on innovating safe, minimally invasive cardiac monitoring systems. Their core product, an esophageal cardiac vital signs monitoring system, aims to enhance patient care by providing a less invasive and more accurate alternative to traditional devices. The company's mission is to improve cardiac care for surgical and ICU patients through advanced technology.

ESO-Tech has demonstrated the efficacy of its technology through clinical studies, showing it as a viable alternative to current invasive methods. The experienced management team drives the company's vision of transforming cardiac monitoring, contributing to better patient outcomes and expanding the scope of cardiac care.

Eso Technologies - Similar Companies

Consano Medical logo

Consano Medical

EpiEP logo

EpiEP

epiep.com

Cardiac Insight logo

Cardiac Insight

CardioOptics logo

CardioOptics

Exostat Medical logo

Exostat Medical

exostatmedical.com

Vital Metrix logo

Vital Metrix

InvisionHeart logo

InvisionHeart

invisionheart.com

EndoGastric Solutions logo

EndoGastric Solutions

Centese logo

Centese

centese.com

EnteroTrack logo

EnteroTrack

enterotrack.com

Twin Star ECS logo

Twin Star ECS

Advanced Telesensors logo

Advanced Telesensors

cardio.io

EndoSound logo

EndoSound

endosound.com

East End Medical logo

East End Medical

iRhythm logo

iRhythm

irhythmtech.com

Eso Technologies - Quick Facts

Who are Eso Technologies' competitors?

Companies similar to Eso Technologies include Consano Medical, EpiEP, Cardiac Insight and CardioOptics.

When was Eso Technologies founded?

Eso Technologies was founded in 2008.

Where is Eso Technologies' headquarters located?

Eso Technologies' headquarters is located in Middleton, WI, US.

When was Eso Technologies' last funding round?

Eso Technologies' most recent funding round was for $590k (USD) in May 2016.

How much has Eso Technologies raised to-date?

As of May 24, 2016, Eso Technologies has raised a total of $2.5M (USD).

How many employees does Eso Technologies have?

Eso Technologies has 6 employees as of Feb 5, 2024.

Eso Technologies - Classification

Industry
  • Hardware
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified